REPLIGEN CORP · Exercise / conversion · Common Stock

What does this filing report?

An SEC Form 4 filing for REPLIGEN CORP records an exercise / conversion involving Common Stock on November 12, 2025. The reported quantity was 25,000. The filing date is November 13, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Filing footnotes & remarks

F1

Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F2

$154.92 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.26 to $155.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3

$155.85 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.28 to $156.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4

$156.65 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.31 to $157.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5

$158.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.41 to $158.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6

$158.51 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.43 to $158.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F7

207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.